MediciNova (MNOV) Announces Development Progress on Intranasal Formulation of SARS-CoV-2 Vaccine for COVID-19 - StreetInsider.com

MediciNova (MNOV) Announces Development Progress on Intranasal Formulation of SARS-CoV-2 Vaccine for COVID-19  StreetInsider.com